Cargando…
Biobanking of human pluripotent stem cells in China
In recent years, significant progress has been made internationally in the development of human pluripotent stem cell (hPSC)‐derived products for serious and widespread disorders. Biobanking of the cellular starting materials is a crucial component in the delivery of safe and regulatory compliant ce...
Autores principales: | Stacey, Glyn Nigel, Hao, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251045/ https://www.ncbi.nlm.nih.gov/pubmed/35652319 http://dx.doi.org/10.1111/cpr.13180 |
Ejemplares similares
-
Human-Mouse Chimerism Validates Human Stem Cell Pluripotency
por: Mascetti, Victoria L., et al.
Publicado: (2016) -
Cortical Astrocyte Progenitors and Astrocytes from Human Pluripotent Stem Cells
por: Battistella, Ingrid, et al.
Publicado: (2023) -
Manufacturing with pluripotent stem cells (PSConf 2021): Key issues for future research and development
por: Stacey, Glyn N., et al.
Publicado: (2022) -
Human Placenta-Derived ECM Supports Tri-Lineage Differentiation of Human Induced Pluripotent Stem Cells
por: Murchison, Angela C., et al.
Publicado: (2020) -
hPSCreg—the human pluripotent stem cell registry
por: Seltmann, Stefanie, et al.
Publicado: (2016)